Skip to main content

Table 3 Relative effect of Robust MANOVA

From: Risk factors for Candida parapsilosis bloodstream infection in a neonatal intensive care unit: a case-control study

Group

Duration of use of CVC

Duration of use of UC

Duration of use of AV

Gestational Age

Birth Weight

1

0.167

0.186

0.720

0.745

0.877

2

0.479

0.394

0.531

0.494

0.490

3

0.395

0.384

0.559

0.540

0.488

4

0.555

0.548

0.567

0.608

0.531

5

0.501

0.514

0.428

0.575

0.462

6

0.515

0.527

0.483

0.488

0.534

7

0.443

0.424

0.539

0.428

0.523

8

0.549

0.518

0.471

0.426

0.409

9

0.552

0.568

0.426

0.424

0.450

10

0.543

0.547

0.464

0.504

0.559